| Contributing Authors |
|
xi | (6) |
| The American Society for Bone and Mineral Research |
|
xvii | (2) |
|
|
|
|
|
|
|
|
|
|
| Preface to the First Edition |
|
xix | (2) |
|
|
|
|
|
| Preface to the Third Edition |
|
xxi | (2) |
|
|
|
|
|
| Acknowledgments |
|
xxiii | |
| Section I. Anatomy and Biology of Bone Matrix and Cellular Elements |
|
3 | (38) |
|
1. Anatomy and Ultrastructure of Bone |
|
|
3 | (8) |
|
|
|
|
|
|
2. Osteoblast Cell Biology -- Lineage and Functions |
|
|
11 | (5) |
|
|
|
|
|
|
|
|
16 | (8) |
|
|
|
|
|
|
4. Bone Matrix Proteins and the Mineralization Process |
|
|
24 | (5) |
|
|
|
|
|
|
|
|
|
|
|
5. Regulation of Bone Remodeling |
|
|
29 | (6) |
|
|
|
|
|
|
6. The Osteoblast Lineage--Embryologic Origins and the Differentiation Sequence |
|
|
35 | (6) |
|
|
|
|
|
|
|
|
|
|
| Section II. Calcium, Magnesium, Phosphorus Homeostasis and Physiology, and Biochemistry of Calcium Regulating Hormones |
|
41 | (50) |
|
7. Calcium, Magnesium and Phosphorus: Intestinal Absorption |
|
|
41 | (8) |
|
|
|
|
|
|
8. Calcium, Magnesium and Phosphorus: Renal Handling and Urinary Excretion |
|
|
49 | (8) |
|
|
|
|
|
|
9. Mineral Balance and Homeostasis |
|
|
57 | (6) |
|
|
|
|
|
|
10. Synthesis, Circulating Heterogeneity, and Metabolism of Parathyroid Hormone |
|
|
63 | (5) |
|
|
|
|
|
|
|
|
|
|
|
11. Parathyroid Hormone: Mechanism of Action |
|
|
68 | (3) |
|
|
|
|
|
|
12. Parathyroid-Hormone-Related Protein |
|
|
71 | (3) |
|
|
|
|
|
|
|
|
|
|
|
13. Vitamin D: Photobiology, Metabolism, Mechanism of Action and Clinical Applications |
|
|
74 | (8) |
|
|
|
|
|
|
|
|
82 | (9) |
|
|
|
|
|
| Section III. Clinical Evaluation of Bone and Mineral Disorders |
|
91 | (86) |
|
15. History and Physical Examination |
|
|
91 | (2) |
|
|
|
|
|
|
|
|
|
|
|
16. Blood, Calcium, Phosphorus, and Magnesium |
|
|
93 | (3) |
|
|
|
|
|
|
17. Parathyroid Hormone and Calcitonin |
|
|
96 | (9) |
|
|
|
|
|
|
|
|
|
|
|
18. Parathyroid-Hormone-Related Protein Assays |
|
|
105 | (4) |
|
|
|
|
|
|
19. Vitamin D Metabolites |
|
|
109 | (5) |
|
|
|
|
|
|
|
|
|
|
|
20. Biochemical Markers of Bone Turnover |
|
|
114 | (5) |
|
|
|
|
|
|
21. Radiologic Evaluation of Bone Mineral in Children |
|
|
119 | (15) |
|
|
|
|
|
|
|
|
|
|
|
22. Scintigraphy in Metabolic Bone Disease |
|
|
134 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23. Bone Density Measurement and the Management of Osteoporosis |
|
|
142 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24. Radiology of Osteoporosis and Other Metabolic Bone Diseases |
|
|
152 | (13) |
|
|
|
|
|
|
25. Bone Biopsy and Histomorphometry in Clinical Practice |
|
|
165 | (3) |
|
|
|
|
|
|
26. Molecular Diagnosis of Bone and Mineral Disorders |
|
|
168 | (9) |
|
|
|
|
|
|
|
|
|
|
| Section IV. Disorders of Serum Minerals |
|
177 | (71) |
|
27. Hypercalcemia: Pathogenesis, Clinical Manifestations, Differential Diagnosis, and Management |
|
|
177 | (4) |
|
|
|
|
|
|
28. Primary Hyperparathyroidism |
|
|
181 | (6) |
|
|
|
|
|
|
29. Familial Hyperparathyroid Syndromes |
|
|
187 | (3) |
|
|
|
|
|
|
|
|
|
|
|
30. Familial Hypocalciuric Hypercalcemia |
|
|
190 | (2) |
|
|
|
|
|
|
31. Tertiary Hyperparathyroidism and Refractory Secondary Hyperparathyroidism |
|
|
192 | (6) |
|
|
|
|
|
|
|
|
|
|
|
32. Humoral Hypercalcemia of Malignancy |
|
|
198 | (5) |
|
|
|
|
|
|
33. Hypercalcemia in Hematologic Malignancies and in Solid Tumors Associated with Extensive Localized Bone Destruction |
|
|
203 | (3) |
|
|
|
|
|
|
34. Hypercalcemia Due to Granuloma-Forming Disorders |
|
|
206 | (3) |
|
|
|
|
|
|
35. Hypercalcemic Syndromes in Infants and Children |
|
|
209 | (4) |
|
|
|
|
|
|
36. Miscellaneous Causes of Hypercalcemia |
|
|
213 | (4) |
|
|
|
|
|
|
|
|
|
|
|
37. Hypocalcemia: Pathogenesis, Differential Diagnosis, and Management |
|
|
217 | (3) |
|
|
|
|
|
|
|
|
220 | (3) |
|
|
|
|
|
|
|
|
|
|
|
39. Parathyroid Hormone Resistance Syndromes |
|
|
223 | (5) |
|
|
|
|
|
|
40. Neonatal Hypocalcemia |
|
|
228 | (2) |
|
|
|
|
|
|
41. Miscellaneous Causes of Hypocalcemia |
|
|
230 | (4) |
|
|
|
|
|
|
|
|
|
|
|
42. Magnesium Depletion and Hypermagnesemia |
|
|
234 | (4) |
|
|
|
|
|
|
43. Hyperphosphatemia and Hypophosphatemia |
|
|
238 | (10) |
|
|
|
|
|
|
|
|
|
|
| Section V. Metabolic Bone Diseases |
|
248 | (114) |
| Section V. Introduction |
|
248 | (1) |
|
|
|
|
|
|
|
|
|
|
|
44. Epidemiology of Osteoporosis |
|
|
249 | (4) |
|
|
|
|
|
|
45. Pathogenesis of Postmenopausal Osteoporosis |
|
|
253 | (1) |
|
|
|
|
|
|
46. Physical Activity and Regulation of Bone Mass |
|
|
254 | (2) |
|
|
|
|
|
|
47. Prevention of Osteoporosis |
|
|
256 | (6) |
|
|
|
|
|
|
48. Nutrition and Osteoporosis |
|
|
262 | (2) |
|
|
|
|
|
|
49. Evaluation and Treatment of Postmenopausal Osteoporosis |
|
|
264 | (8) |
|
|
|
|
|
|
|
|
|
|
|
50. The Special Problem of Hip Fracture |
|
|
272 | (3) |
|
|
|
|
|
|
51. Juvenile Osteoporosis |
|
|
275 | (3) |
|
|
|
|
|
|
52. Glucocorticoid and Drug-Induced Osteoporosis |
|
|
278 | (5) |
|
|
|
|
|
|
|
|
283 | (3) |
|
|
|
|
|
|
54. Hyperthryoidism, Thyroid Hormone Replacement, and Osteoporosis |
|
|
286 | (3) |
|
|
|
|
|
|
55. Miscellaneous Causes of Osteoporosis |
|
|
289 | (4) |
|
|
|
|
|
|
56. Orthopeidc Complications of Osteoporosis |
|
|
293 | (6) |
|
|
|
|
|
|
57. Osteoporosis and Rheumatic Diseases |
|
|
299 | (2) |
|
|
|
|
|
|
58. Nutritional Rickets and Osteomalacia |
|
|
301 | (5) |
|
|
|
|
|
|
59. Metabolic Bone Disease in Gastrointestinal, Hepatobiliary, and Pancreatic Disorders |
|
|
306 | (5) |
|
|
|
|
|
|
|
|
|
|
|
60. Vitamin D-Dependent Rickets |
|
|
311 | (5) |
|
|
|
|
|
|
|
|
|
|
|
61. Hypophosphatemic Vitamin D-Resistant Rickets |
|
|
316 | (3) |
|
|
|
|
|
|
62. Tumor-Induced Rickets and Osteomalacia |
|
|
319 | (7) |
|
|
|
|
|
|
|
|
326 | (2) |
|
|
|
|
|
|
64. Fanconi Syndrome and Renal Tubular Acidosis |
|
|
328 | (5) |
|
|
|
|
|
|
65. Drug-Induced Osteomalacia |
|
|
333 | (4) |
|
|
|
|
|
|
66. Metabolic Bone Disease of Total Parenteral Nutrition |
|
|
337 | (4) |
|
|
|
|
|
|
67. Renal Osteodystrophy in Adults and Children |
|
|
341 | (21) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Section VI. Genetic, Developmental, and Dysplastic Skeletal Disorders |
|
362 | (28) |
| Section VI. Introduction |
|
362 | (1) |
|
|
|
|
|
|
68. Sclerosing Bone Dysplasias |
|
|
363 | (17) |
|
|
|
|
|
|
|
|
380 | (2) |
|
|
|
|
|
|
70. Osteogenesis Imperfecta |
|
|
382 | (3) |
|
|
|
|
|
|
71. Chondrodystrophies and Mucopolysaccharidoses |
|
|
385 | (5) |
|
|
|
|
|
| Section VII. Acquired Disorders of Cartilage and Bone |
|
390 | (19) |
| Section VII. Introduction |
|
390 | (1) |
|
|
|
|
|
|
|
|
391 | (8) |
|
|
|
|
|
|
73. Ischemic Bone Disease |
|
|
399 | (4) |
|
|
|
|
|
|
74. Infiltrative Disorders of Bone |
|
|
403 | (6) |
|
|
|
|
|
| Section VIII. Paget's Disease |
|
409 | (13) |
|
75. Paget's Disease of Bone |
|
|
409 | (13) |
|
|
|
|
|
| Section IX. Extraskeletal (Ectopic) Calcification and Ossification |
|
422 | (10) |
| Section IX. Introduction |
|
422 | (2) |
|
|
|
|
|
|
|
|
424 | (2) |
|
|
|
|
|
|
|
|
426 | (2) |
|
|
|
|
|
|
78. Fibrodysplasia (Myositis) Ossificans Progressive |
|
|
428 | (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Section X. Nephrolithiasis |
|
432 | (15) |
| Section X. Introduction |
|
432 | (1) |
|
|
|
|
|
|
|
|
433 | (5) |
|
|
|
|
|
|
|
|
|
|
|
80. Urologic Aspects of Nephrolithiasis Management |
|
|
438 | (9) |
|
|
|
|
|
| Section XI. Appendix |
|
447 | (20) |
|
i. Growth Charts for Males and Females |
|
|
447 | (2) |
|
|
|
449 | (2) |
|
iii. Laboratory Values of Importance for Calcium Metabolism and Metabolic Bone Disease |
|
|
451 | (2) |
|
iv. Mineral and Vitamin D RDAs for Infants, Children, and Adults |
|
|
453 | (1) |
|
v. Formulary of Drugs Commonly Used in Treatment of Mineral Disorders |
|
|
454 | (4) |
|
vi. Structure of Naturally Occurring Vitamin D and Synthetic Analogs |
|
|
458 | (1) |
|
|
|
459 | (4) |
|
viii. Bone Density Reference Data |
|
|
463 | (4) |
| Subject Index |
|
467 | |
Other versions by this Author
